Back to search results

Digital Intervention for Self-Stigma in Pregnant and Postpartum Women with Substance Use Disorder

This study is testing a digital tool called Enhearten with EMI to help pregnant and new mothers (up to 12 months postpartum) who have a substance use disorder. Enhearten with EMI is designed to help reduce feelings of self-stigma (negative feelings about oneself due to substance use) and improve treatment outcomes. Researchers want to see if using this tool can help women feel better about themselves and stick with their treatment. The study is looking for women aged 18 and older who are fluent in English and have daily access to a smartphone or tablet. Success will be measured by changes in self-stigma and internalized stigma about substance use over six months. The current recruitment status is unclear.

Study design
This is an interventional study planning to enroll 152 participants. It will compare the Enhearten with EMI digital intervention to a waitlist control group.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for six months after the intervention to measure self-stigma and internalized stigma.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07211867

A Digital Intervention to Decrease Self-Stigma Among Pregnant and Postpartum Women With Substance Use Disorder

Recruiting
NAAges 18+InterventionalTreatment
Washington University School of Medicine
~152 participants
Updated 2025-11-26 on ClinicalTrials.gov
What's tested:Enhearten with EMIWaitlist Control Group

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Self-stigma about substance use
Measured over Baseline through 6-months post-intervention
+1 more outcome measured

Conditions

Substance Use Disorder

Explore related trials

Substance use disorder

Where it's being run

1 sites across 1 states
Missouri1

Study leadership

  • Alex T Ramsey, Ph.D. · PRINCIPAL_INVESTIGATOR · Washington University School of Medicine

Who to contact

Alex T Ramsey, Ph.D.
[email protected]
314-362-5370
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Pregnant women and new mothers (up to 12 months postpartum)
Adult (≥18 years of age)
Fluent in English
Currently owns or has ready (daily) access to a smartphone or tablet to use Enhearten.
Self-reports a history of substance use, excluding alcohol use, nicotine/tobacco use, and drugs taken as prescribed by a physician OR a history of substance use, excluding alcohol use, nicotine/tobacco use, and drugs taken as prescribed by a physician, is identified in chart review as documented by a healthcare provider

What this trial measures

  • Self-stigma about substance useBaseline through 6-months post-intervention

    Participants in each group will be assessed on levels of perceived self-stigma using the Brief Substance Use Stigma Scale ). The Brief Substance Use Stigma Scale uses a 5-point Likert scale, ranging from "strongly disagree" to "strongly agree". Mean scores will be created with higher scores indicating higher levels of stigma.

  • Internalized stigma about substance useBaseline through 6-months post-intervention

    Participants in each group will be assessed on levels of perceived self-stigma using the Internalized Stigma of Substance Abuse Scale (ISSA). The Internalized Stigma of Substance Abuse Scale (ISSA) uses a 4-point Likert scale ranging from "strongly disagree" to "strongly agree". Mean scores will be created with higher scores indicating higher levels of stigma.